As part of this year's annual meeting of the Society for Thrombosis and Haemostasis Research (GTH), held from February 18–21, 2025, in Lausanne, the Rudolf Marx Scholarship was awarded to Priv.-Doz. Dr. med. univ. Oliver Königsbrügge, PhD from the Thrombosis and Hemostasis Research Group of the Clinical Division of Hematology and Hemostasis.
The Rudolf Marx Scholarship supports a scientific project titled "Comprehensive assessment of the ex-vivo factor equivalence of non-factor hemophilia therapies", which will be conducted by Dr. Königsbrügge at the Hemophilia Center of Nagoya University Medical School in Japan during a six-month research stay.
Dr. Königsbrügge's academic research focuses on non-factor-based bleeding prophylaxis in congenital hemophilia and its evaluation through laboratory coagulation analyses.